This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money' Recap: Tide's Right at I-Flow

Click here for an archive of Cramer's "Mad Money" recaps.


It's time to buy I-Flow (IFLO), Jim Cramer told viewers of his "Mad Money" TV show Friday.

The medical device company has a great concept and there are good reasons to buy the stock, he said, but those reasons really have begun to matter only now.

"It has a great story, but it didn't become compelling until it got a major haircut and became a bargain hunter's dream," he said.

I-Flow has a product that hospitals, patients and doctors all liked, but the stock has been too expensive, he said.

But then the company missed the consensus Wall Street revenue estimate by 4% and the stock dropped to $13.50. Cramer called the results a little disappointing, but not enough to justify the sharp drop in price.

I-Flow wasn't owned by growth junkies or people who could take a small revenue miss in stride, he said. "They panicked, plain and simple ... a terrible way to invest and a terrific way to lose money."

Cramer said that now could be the time for investors with cooler heads to buy I-Flow, whose main product is a pump called the ON-Q pain relief system. This post-operative device automatically delivers a continuous infusion of a local anesthetic for up to five hours directly to the treatment area, and it's being used with just about every type of procedure, he said.

This means that the patient is out of the hospital earlier, which hospitals and insurance companies like, he added.
1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BWS $30.70 -0.74%
MRVC $12.50 0.00%
SHOO $42.44 0.00%
AAPL $126.44 0.00%
FB $87.28 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs